SEC 13F Intelligence

Folger Nolan Fleming Douglas Capital Management, Inc / MRK

Folger Nolan Fleming Douglas Capital Management, Inc’s Merck & Co Inc Position

Does Folger Nolan Fleming Douglas Capital Management, Inc own Merck & Co Inc (MRK)? Yes — 127.8K shares worth $16M (+1.34% of its 13F portfolio) as of Q2 2026, down from 128.4K shares the prior filed quarter.

Position Value
$16M
Q2 2026
Shares
127.8K
% of Portfolio
+1.34%
Quarters Held
31
currently held

Position History MRK

Reported value by quarter
Q4 ’18: $6MQ4 ’18Q1 ’19: $6MQ2 ’19: $6MQ3 ’19: $6MQ4 ’19: $7MQ4 ’19Q1 ’20: $6MQ2 ’20: $6MQ3 ’20: $6MQ4 ’20: $6MQ4 ’20Q1 ’21: $6MQ2 ’21: $6MQ3 ’21: $7MQ4 ’21: $7MQ4 ’21Q1 ’22: $7MQ2 ’22: $8MQ3 ’22: $7MQ4 ’22: $10MQ4 ’22Q1 ’23: $10MQ2 ’23: $11MQ3 ’23: $8MQ4 ’23: $9MQ4 ’23Q1 ’24: $10MQ2 ’24: $10MQ3 ’24: $9MQ4 ’24: $7MQ4 ’24Q1 ’25: $6MQ2 ’25: $5MQ3 ’25: $6MQ4 ’25: $7MQ4 ’25Q1 ’26: $15MQ2 ’26: $16Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 2026127.8K$16M+1.34%
Q1 2026128.4K$15M+1.38%
Q4 202569.0K$7M+0.75%
Q3 202569.3K$6M+0.61%
Q2 202568.9K$5M+0.61%
Q1 202569.4K$6M+0.70%
Q4 202469.4K$7M+0.72%
Q3 202475.3K$9M+0.84%
Q2 202477.7K$10M+0.98%
Q1 202478.6K$10M+1.06%
Q4 202379.1K$9M+0.94%
Q3 202379.8K$8M+0.96%
Q2 202391.0K$11M+1.14%
Q1 202390.1K$10M+1.12%
Q4 202292.7K$10M+1.25%
Q3 202286.3K$7M+1.01%
Q2 202285.5K$8M+1.02%
Q1 202287.3K$7M+0.80%
Q4 202187.1K$7M+0.73%
Q3 202187.2K$7M+0.79%
Q2 202180.5K$6M+0.72%
Q1 202178.5K$6M+0.74%
Q4 202076.7K$6M+0.83%
Q3 202077.9K$6M+0.97%
Q2 202076.3K$6M+0.96%
Q1 202074.8K$6M+1.15%
Q4 201974.7K$7M+0.99%
Q3 201975.2K$6M+0.98%
Q2 201973.7K$6M+0.92%
Q1 201972.9K$6M+0.91%
Q4 201872.7K$6M+0.91%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Folger Nolan Fleming Douglas Capital Management, Inc’s full portfolio or all institutional holders of MRK.